Glucotrack plans to file for an investigational device exemption in the second quarter, with hopes of starting a trial in the ...

Join us in Minneapolis to hear more from keynote speaker Lisa Earnhardt, at DeviceTalks Minnesota on May 4, 2026.

Glucotrack (Nasdaq:GCTK) today provided an update on the planned regulatory timeline for its continuous blood glucose monitor ...

(Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies for people with diabetes, today provided a ...

Advances in microfluidic biosensors and materials science transformed sweat into a reliable, high-quality data stream capable ...

Transitioning from multiple daily injections to a tubeless automated insulin delivery (AID) system significantly improves HbA1c in T1D.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Since its launch in 2025, more than one million users have adopted the Ottai CGM.

Chronic disease management stands at an inflection point. Globally, the number of people living with diabetes continues to climb, and healthcare systems in both developed and emerging markets are ...

According to the in-depth market research report published by MarkNtel Advisors, the Wearable Health Devices Market in GCC is projected to grow at a CAGR of around 14.7% during 2026–2032, reflecting ...

As technology and healthcare increasingly converge, Chinese startup Feipu Tech is exploring how non-invasive health check ...

A lawsuit alleges that the state’s prisons limit access to insulin pumps and glucose monitors, putting people with Type 1 ...